EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-05-0056
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Glioblastoma Multiforme: Novel Therapeutic Approaches

ISRN Neurology
2012English

Comprehensive Portrait of Recurrent Glioblastoma Multiforme in Molecular and Clinical Characteristics

Oncotarget
Oncology
2015English

Glioblastoma Multiforme Cerebelar

JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA
2018English

Analysis of Oncogenic Signaling Networks in Glioblastoma Identifies ASPM as a Molecular Target

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Tumor-Associated Macrophages in Glioblastoma Multiforme—A Suitable Target for Somatostatin Receptor-Based Imaging and Therapy?

PLoS ONE
Multidisciplinary
2015English

Glioblastoma Multiforme and Ascending Weakness

Canadian Journal of Neurological Sciences
MedicineNeurology
2002English

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma

Clinical Medicine Insights: Oncology
Oncology
2015English

Biomarkers and Therapeutic Advances in Glioblastoma Multiforme

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Glioblastoma Multiforme in a Patient With Isolated Hemimegalencephaly

Journal of Neurological Surgery Reports
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy